Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. (Q44828678)
Jump to navigation
Jump to search
scientific article published in January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. |
scientific article published in January 2004 |
Statements
Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration (English)
Gobbo OL
1 reference
1 January 2004